Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


30.12.2018

1 Am J Surg Pathol
2 Blood
1 BMC Cancer
4 Br J Haematol
1 Cancer Lett
4 Haematologica
1 Int J Cancer
1 J Clin Oncol
3 Leuk Lymphoma
1 PLoS Comput Biol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. HUANG Y, Shi X, Zhong P, Wang Y, et al
    De Novo Testicular Extranodal NK/T-Cell Lymphoma: A Clinicopathologic Study of 21 Cases With Review of Additional 18 Cases in the Literature.
    Am J Surg Pathol. 2018 Dec 26. doi: 10.1097/PAS.0000000000001210.
    PubMed     Text format     Abstract available


    Blood

  2. ANDOR N, Simonds EF, Czerwinski DK, Chen J, et al
    Single-cell RNA-Seq of lymphoma cancers reveals malignant B cell types and co-expression of T cell immune checkpoints.
    Blood. 2018 Dec 27. pii: blood-2018-08-862292. doi: 10.1182/blood-2018-08-862292
    PubMed     Text format     Abstract available

  3. OPSTAL-VAN WINDEN AWJ, de Haan HG, Hauptmann M, Schmidt MK, et al
    Genetic susceptibility to radiation-induced breast cancer after Hodgkin Lymphoma.
    Blood. 2018 Dec 20. pii: blood-2018-07-862607. doi: 10.1182/blood-2018-07-862607
    PubMed     Text format     Abstract available


    BMC Cancer

  4. TAROKHIAN H, Rahimi H, Mosavat A, Shirdel A, et al
    HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    BMC Cancer. 2018;18:1287.
    PubMed     Text format     Abstract available


    Br J Haematol

  5. HILL BT, Nastoupil L, Winter AM, Becnel MR, et al
    Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma.
    Br J Haematol. 2018 Dec 21. doi: 10.1111/bjh.15720.
    PubMed     Text format     Abstract available

  6. EVENS AM
    Important new developments in Hodgkin Lymphoma.
    Br J Haematol. 2019;184:6.
    PubMed     Text format    

  7. BOLL B, Plutschow A, Burkle C, Atta J, et al
    Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
    Br J Haematol. 2018 Dec 28. doi: 10.1111/bjh.15741.
    PubMed     Text format     Abstract available

  8. NAKAYAMA S, Taniguchi T, Tanaka H, Espinoza JL, et al
    Interleukin-17-producing angioimmunoblastic T-cell lymphoma with Evans syndrome.
    Br J Haematol. 2018 Dec 28. doi: 10.1111/bjh.15733.
    PubMed     Text format    


    Cancer Lett

  9. PORCELLI L, Stolfa D, Stefanachi A, Di Fonte R, et al
    Synthesis and biological evaluation OF N-biphenyl-nicotinic based Moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin lymphoma.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30728.
    PubMed     Text format     Abstract available


    Haematologica

  10. SEYMOUR JF, Marcus R, Davies A, Gallop-Evans E, et al
    Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
    Haematologica. 2018 Dec 20. pii: haematol.2018.209015.
    PubMed     Text format     Abstract available

  11. PHILLIPS AA, Fields PA, Hermine O, Ramos JC, et al
    Mogamulizumab versus investigator choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.
    Haematologica. 2018 Dec 20. pii: haematol.2018.205096.
    PubMed     Text format     Abstract available

  12. BELHADJ M, Mansour D, Kaltenbach S, Deau-Fischer B, et al
    T-cell large granular lymphocyte leukemia transformation into aggressive T-cell lymphoma: a report of two cases with molecular characterization.
    Haematologica. 2018 Dec 20. pii: haematol.2018.205542.
    PubMed     Text format    

  13. QUALLS D, Abramson JS
    Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma.
    Haematologica. 2018 Dec 20. pii: haematol.2018.195834.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. SOLANS M, Benavente Y, Saez M, Agudo A, et al
    Adherence to the Mediterranean diet and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32091.
    PubMed     Text format     Abstract available


    J Clin Oncol

  15. ADAMS HJA, Kwee TC
    Standardized Definition of Progression-Free Survival in Diffuse Large B-Cell Lymphoma Is Urgently Needed.
    J Clin Oncol. 2018 Dec 28:JCO1801134. doi: 10.1200/JCO.18.01134.
    PubMed     Text format    


    Leuk Lymphoma

  16. ZINTER MS, Melton A, Sabnis AJ, Dvorak CC, et al
    Pulmonary veno-occlusive disease in a pediatric hematopoietic stem cell transplant patient: a cautionary tale.
    Leuk Lymphoma. 2017 Sep 28:1-4. doi: 10.1080/10428194.2017.1382697.
    PubMed     Text format    

  17. ROSWARSKI J, Roschewski M, Lucas A, Melani C, et al
    Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.
    Leuk Lymphoma. 2018;59:1466-1469.
    PubMed     Text format    

  18. STRATI P, Tang G, Duose DY, Mallampati S, et al
    Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Leuk Lymphoma. 2018;59:1672-1676.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  19. CHEN X, Yin J, Qu J, Huang L, et al
    MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction.
    PLoS Comput Biol. 2018;14:e1006418.
    PubMed     Text format     Abstract available


    PLoS One

  20. DIAS JNR, Andre AS, Aguiar SI, Ministro J, et al
    Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
    PLoS One. 2018;13:e0208147.
    PubMed     Text format     Abstract available

  21. YAN LX, Liu YH, Luo DL, Zhang F, et al
    Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
    PLoS One. 2018;13:e0210027.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: